Full-Time

Electrical Automation Engineer 2

Updated on 5/9/2026

Smith+Nephew

Smith+Nephew

10,001+ employees

Global medical devices for orthopedics

No salary listed

Fort Worth, TX, USA

Hybrid

Hybrid work model; on-site presence in Fort Worth, TX required.

Category
Biology & Biotech (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor's degree required in engineering or related field
  • Electrical Engineering degree is preferred
  • Minimum 3 years of experience in a Pharmaceutical/Biotech environment or a minimum of 1 year in an Automation Engineer role with consistent performance
  • Strong working knowledge and experience of PLCs, HMIs, and SCADA systems
  • Demonstrated experience in project management of automation solutions with proven results
  • Design documentation, Equipment manual, and P&ID interpretation (in English)
  • Adherence to Quality Systems and Good Manufacturing Practices with proper attention to detail
  • Ability to work in a professional, multi-disciplinary, multi-cultural team as a group leader, facilitator, or participant
  • Ability to influence team members, peers, and senior managers
  • Strong analytical and troubleshooting skills
  • Ability to prioritize multiple projects along with multitasking
  • Effective verbal and written communication skills
  • Ability to identify opportunities to implement automated systems and optimize existing automation processes
  • Software: MS Project or Excel, Word, and PowerPoint
Responsibilities
  • Function as an Automation Subject Matter Expert (SME) to equipment or systems regarding troubleshooting operations and/or changes to improve efficiency. Required to be actively involved in daily operations when required to meet schedules or to resolve complex problems.
  • Routinely audit the operational performance and regulatory compliance of a moderate number of equipment items or systems of significant complexity.
  • Work with multiple departments in developing requirements and recommendations for system modifications.
  • Guiding and mentoring junior team members on automation best practices and methodologies.
  • Technical translation and execution of all validation requirements for new and/or modified manufacturing, and utilities equipment/systems, ensuring equipment and utility systems are available for GMP Manufacturing, in a state of compliance, and reliably performing to their validated function.
  • Active participation of Factory Acceptance Testing (FAT), Commissioning of new equipment, IQ/OQ/PQ, Validation Summary Reports, Part 11 Compliance, etc, as required for Manufacturing, Utilities, and Computerized systems.
  • Develop and lead one or more projects, ensuring technical alignment with the commercial and marketing strategy for the project and managing the project and project team to key milestones and targets.
  • Drives the development and operational delivery of the project plan in accordance with Project Management best practices, Smith+Nephew SOPs and Guidance Documents, and the product profile.
  • Manages Project risks, budget, schedule variance, and change management for the project.
  • Reports to executive management as appropriate.
  • Completes capital requests and purchase orders as needed to support projects.
  • Generate any associated quality documentation requirements such as SOPs, Change Controls, URS, Room Specification, Validation protocols, Job Plan instructions, Non-Conformances, and CAPAs.
  • Will also perform Risk Assessments and/or Gap assessments for equipment, process, method, and/or facility tech transfers.
Desired Qualifications
  • Electrical Engineering Degree is preferred
  • EIT/PE License preferred
  • Lean/Six Sigma certification highly desired
  • PMP certification a plus
  • Knowledge of aseptic manufacturing and fermentation processes is a plus
  • Travel up to 10% (international and domestic)
  • Any other listed benefits or cultural statements not included here are not categorized as Desirable unless explicitly stated

Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.

Company Size

10,001+

Company Stage

IPO

Headquarters

Watford, United Kingdom

Founded

1856

Simplify Jobs

Simplify's Take

What believers are saying

  • Innovation drove over 60% of 2025 growth; products launched past five years deliver double-digit growth.
  • Free cash flow surged 52.5% to $840M, enabling $500M share buyback and strategic acquisitions.
  • Integrity Orthopaedics acquisition expands $875M rotator cuff repair market with proven clinical outcomes.

What critics are saying

  • Memphis manufacturing consolidation creates single-point-of-failure for orthopedics production in 12-24 months.
  • Integrity acquisition's $225M performance milestones depend on unproven Tendon Seam technology achieving adoption.
  • Chinese pricing reforms and US reimbursement headwinds compress margins simultaneously in 2026.

What makes Smith+Nephew unique

  • Tendon Seam rotator cuff technology addresses 500,000 annual US procedures with lower re-tear rates.
  • ALLEVYN COMPLETE CARE releases 100 times fewer bacteria than competing foam dressings.
  • RENASYS EDGE achieves 88% patient compliance with lightweight, modular negative pressure system.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Smith+Nephew who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Parental Leave

Fertility Treatment Support

Family Planning Benefits

Tuition Reimbursement

Wellness Program

Mental Health Support

Volunteer Time Off

Home Office Stipend

Phone/Internet Stipend

Discounted Stock Options

Health Savings Account/Flexible Spending Account

Employee Assistance Program

PTO/vacation?

Paid Sick Leave

Company News

Yahoo Finance
Mar 4th, 2026
Smith & Nephew reports $6.2B revenue with 5.3% growth and 53% jump in free cash flow

Smith & Nephew reported strong full-year 2025 results, with revenue of $6.2 billion representing 5.3% underlying growth and 6.1% reported growth. Fourth-quarter revenue reached $1.7 billion, growing 6.2% on an underlying basis. The medical device company achieved 160 basis points of margin expansion, with trading profit of $1.2 billion and adjusted earnings per share of $1.02, up 21%. Free cash flow increased 52.5% year-on-year to $840 million, enabling completion of a $500 million share buyback programme. Innovation drove over 60% of growth, with products launched in the past five years delivering double-digit growth across all business units. For 2026, the company expects 6% organic revenue growth and 8% trading profit growth to around $1.3 billion, though it faces headwinds from Chinese pricing reforms and US reimbursement changes.

Yahoo Finance
Feb 25th, 2026
Smith & Nephew signs exclusive US distribution deal with RMR Ortho for A'TOMIC Nitinol Fixation System

Smith+Nephew has signed an exclusive US distribution agreement with RMR Ortho to add the A'TOMIC Nitinol Fixation System to its Trauma, Foot & Ankle and Hand & Wrist portfolio. The partnership enables Smith+Nephew to expand its participation in high-frequency fracture and arthrodesis procedures whilst utilising its existing Extremities and Trauma sales channel. The dynamic compression fixation solution complements the company's current technologies. Scott Gunn, Vice President of US Marketing at Smith+Nephew, said the collaboration reflects the company's disciplined approach to portfolio expansion and continued focus on driving sustainable growth.

Investegate Ltd
Jan 12th, 2026
Smith+Nephew acquires Integrity Orthopaedics for $225M plus $225M in performance payments

Smith+Nephew has acquired Integrity Orthopaedics for an initial $225 million cash payment, plus up to $225 million in performance-based payments over five years. The deal strengthens Smith+Nephew's sports medicine portfolio with the Tendon Seam rotator cuff repair technology. Founded in 2020, Integrity Orthopaedics developed the innovative system to address high failure rates in traditional rotator cuff repairs. The technology uses patented micro-anchors and continuous suture designed to deliver stronger repairs and lower re-tear rates. Early clinical results show reduced pain and shorter recovery times. The rotator cuff repair market performs approximately 500,000 procedures annually in the US, valued at $875 million. The acquisition, expected to close by end of January 2026, will be financed from existing cash facilities and is expected to be accretive to trading profit margin by 2028.

Startupticker.ch
Jun 2nd, 2025
Smith & Nephew acquires Atracsys to expand its digital surgery ecosystem

Download the Swiss reference publication on investments, investors and exits in our assets section.

The Manila Times
Mar 11th, 2025
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for robotics, knees, hips, and shoulders at AAOS 2025.